L. Ybarlucea

EGFR Expression Is Unreliable to Decide for Cetuximab Treatment in Patients with Metastatic Colorectal Cancer: Results from “ERBITUX-OUEST”

J. Douillard, N. Padilla, J. Raoul, 2016 .

Phase II trial combining docetaxel and doxorubicin as neoadjuvant chemotherapy in patients with operable breast cancer.

P. Fumoleau, V. Diéras, T. Bachelot, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.